Terms: = Breast cancer AND FANCG, ENSG00000221829, 2189, O15287, XRCC9, FAG
48 results:
1. Mutations of TP53 and genes related to homologous recombination repair in breast cancer with germline BRCA1/2 mutations.
Kim J; Jeong K; Jun H; Kim K; Bae JM; Song MG; Yi H; Park S; Woo GU; Lee DW; Kim TY; Lee KH; Im SA
Hum Genomics; 2023 Jan; 17(1):2. PubMed ID: 36604691
[TBL] [Abstract] [Full Text] [Related]
2. Distinct clinicopathological characteristics, genomic alteration and prognosis in breast cancer with concurrent TP53 mutation and MYC amplification.
Lin X; Lin X; Guo L; Wang Y; Zhang G
Thorac Cancer; 2022 Dec; 13(24):3441-3450. PubMed ID: 36305094
[TBL] [Abstract] [Full Text] [Related]
3. Physical functioning, frailty and risks of locally-advanced breast cancer among older women.
Coleman C; Yan CH; Ko NY; Nabulsi NA; Hoskins KF; Chiu BC; Calip GS
Breast; 2022 Aug; 64():19-28. PubMed ID: 35468476
[TBL] [Abstract] [Full Text] [Related]
4. Fanconi Anemia Patients from an Indigenous Community in Mexico Carry a New Founder Pathogenic Variant in
Reyes P; García-de Teresa B; Juárez U; Pérez-Villatoro F; Fiesco-Roa MO; Rodríguez A; Molina B; Villarreal-Molina MT; Meléndez-Zajgla J; Carnevale A; Torres L; Frias S
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216452
[TBL] [Abstract] [Full Text] [Related]
5. Performance, clinical utility, and cost-effectiveness of selective use of staging investigations in early breast cancers.
James J; Teo M; Ramachandran V; Law M; Cheng M
ANZ J Surg; 2022 Mar; 92(3):426-430. PubMed ID: 34723441
[TBL] [Abstract] [Full Text] [Related]
6. Quality indicators for breast cancer care: A systematic review.
Maes-Carballo M; Gómez-Fandiño Y; Reinoso-Hermida A; Estrada-López CR; Martín-Díaz M; Khan KS; Bueno-Cavanillas A
Breast; 2021 Oct; 59():221-231. PubMed ID: 34298301
[TBL] [Abstract] [Full Text] [Related]
7. Preexisting morbidity profile of women newly diagnosed with breast cancer in sub-Saharan Africa: African breast cancer-Disparities in Outcomes study.
Ayeni OA; Norris SA; Joffe M; Cubasch H; Galukande M; Zietsman A; Parham G; Adisa C; Anele A; Schüz J; Anderson BO; Foerster M; Dos Santos Silva I; McCormack VA
Int J Cancer; 2021 May; 148(9):2158-2170. PubMed ID: 33180326
[TBL] [Abstract] [Full Text] [Related]
8. NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls.
Solomon JP; Linkov I; Rosado A; Mullaney K; Rosen EY; Frosina D; Jungbluth AA; Zehir A; Benayed R; Drilon A; Hyman DM; Ladanyi M; Sireci AN; Hechtman JF
Mod Pathol; 2020 Jan; 33(1):38-46. PubMed ID: 31375766
[TBL] [Abstract] [Full Text] [Related]
9. Analysis of polymorphisms in genes associated with the FA/BRCA pathway in three patients with multiple primary malignant neoplasms.
Wang L; Wang H; Wang T; Liu J; Chen W; Wang Y; Chen C; Zhu H; Dai P
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1101-1112. PubMed ID: 30942098
[TBL] [Abstract] [Full Text] [Related]
10. A review on role of ATM gene in hereditary transfer of colorectal cancer.
Sriramulu S; Ramachandran M; Subramanian S; Kannan R; Gopinath M; Sollano J; Bissi L; Banerjee A; Marotta F; Pathak S
Acta Biomed; 2019 Jan; 89(4):463-469. PubMed ID: 30657113
[TBL] [Abstract] [Full Text] [Related]
11. The identification of pathogenic variants in BRCA1/2 negative, high risk, hereditary breast and/or ovarian cancer patients: High frequency of FANCM pathogenic variants.
Schubert S; van Luttikhuizen JL; Auber B; Schmidt G; Hofmann W; Penkert J; Davenport CF; Hille-Betz U; Wendeburg L; Bublitz J; Tauscher M; Hackmann K; Schröck E; Scholz C; Wallaschek H; Schlegelberger B; Illig T; Steinemann D
Int J Cancer; 2019 Jun; 144(11):2683-2694. PubMed ID: 30426508
[TBL] [Abstract] [Full Text] [Related]
12. A historical cohort study on glycemic-control and cancer-risk among patients with diabetes.
Dankner R; Boker LK; Boffetta P; Balicer RD; Murad H; Berlin A; Olmer L; Agai N; Freedman LS
Cancer Epidemiol; 2018 Dec; 57():104-109. PubMed ID: 30388485
[TBL] [Abstract] [Full Text] [Related]
13. Impaired retinal pigment epithelium in paclitaxel-induced macular edema: A case report.
Shih CH; Lee YC
Medicine (Baltimore); 2018 Jun; 97(26):e11229. PubMed ID: 29952984
[TBL] [Abstract] [Full Text] [Related]
14. Comparative Performance of breast cancer Human Epidermal Growth Factor Receptor 2 Fluorescence In Situ Hybridization and Brightfield In Situ Hybridization on College of American Pathologists Proficiency Tests.
Geiersbach KB; Bridge JA; Dolan M; Jennings LJ; Persons DL; Souers RJ; Tsuchiya KD; Vasalos PH; Moncur JT
Arch Pathol Lab Med; 2018 Oct; 142(10):1254-1259. PubMed ID: 29733681
[TBL] [Abstract] [Full Text] [Related]
15. Gene panel testing of 5589 BRCA1/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary breast and Ovarian cancer.
Hauke J; Horvath J; Groß E; Gehrig A; Honisch E; Hackmann K; Schmidt G; Arnold N; Faust U; Sutter C; Hentschel J; Wang-Gohrke S; Smogavec M; Weber BHF; Weber-Lassalle N; Weber-Lassalle K; Borde J; Ernst C; Altmüller J; Volk AE; Thiele H; Hübbel V; Nürnberg P; Keupp K; Versmold B; Pohl E; Kubisch C; Grill S; Paul V; Herold N; Lichey N; Rhiem K; Ditsch N; Ruckert C; Wappenschmidt B; Auber B; Rump A; Niederacher D; Haaf T; Ramser J; Dworniczak B; Engel C; Meindl A; Schmutzler RK; Hahnen E
Cancer Med; 2018 Apr; 7(4):1349-1358. PubMed ID: 29522266
[TBL] [Abstract] [Full Text] [Related]
16. BRIP1 loss-of-function mutations confer high risk for familial ovarian cancer, but not familial breast cancer.
Weber-Lassalle N; Hauke J; Ramser J; Richters L; Groß E; Blümcke B; Gehrig A; Kahlert AK; Müller CR; Hackmann K; Honisch E; Weber-Lassalle K; Niederacher D; Borde J; Thiele H; Ernst C; Altmüller J; Neidhardt G; Nürnberg P; Klaschik K; Schroeder C; Platzer K; Volk AE; Wang-Gohrke S; Just W; Auber B; Kubisch C; Schmidt G; Horvath J; Wappenschmidt B; Engel C; Arnold N; Dworniczak B; Rhiem K; Meindl A; Schmutzler RK; Hahnen E
Breast Cancer Res; 2018 Jan; 20(1):7. PubMed ID: 29368626
[TBL] [Abstract] [Full Text] [Related]
17. [Pleuropulmonary metastases originating from extra-thoracic neoplasia].
Badri F; Batahar SA; Idrissi SE; Sajiai H; Serhane H; Amro L
Pan Afr Med J; 2017; 26():44. PubMed ID: 28451022
[TBL] [Abstract] [Full Text] [Related]
18. Flat epithelial atypia on core needle biopsy, must we surgically excise?
Acott AA; Mancino AT
Am J Surg; 2016 Dec; 212(6):1211-1213. PubMed ID: 27832842
[TBL] [Abstract] [Full Text] [Related]
19. Time-Dependent Risk of cancer After a Diabetes Diagnosis in a Cohort of 2.3 Million Adults.
Dankner R; Boffetta P; Balicer RD; Boker LK; Sadeh M; Berlin A; Olmer L; Goldfracht M; Freedman LS
Am J Epidemiol; 2016 Jun; 183(12):1098-106. PubMed ID: 27257115
[TBL] [Abstract] [Full Text] [Related]
20. Candidate gene analysis of BRCA1/2 mutation-negative high-risk Russian breast cancer patients.
Sokolenko AP; Preobrazhenskaya EV; Aleksakhina SN; Iyevleva AG; Mitiushkina NV; Zaitseva OA; Yatsuk OS; Tiurin VI; Strelkova TN; Togo AV; Imyanitov EN
Cancer Lett; 2015 Apr; 359(2):259-61. PubMed ID: 25619955
[TBL] [Abstract] [Full Text] [Related]
[Next]
